The interleukin-23/interleukin-17 immune axis as a promising... : Current Opinion in
Rheumatology The interleukin-23/interleukin-17 immune axis as a promising new target in the …

Spondyloarthritis (SpA) is a chronic immune-mediated inflammatory disease with diverse
phenotypic manifestations including spondylitis, arthritis, enthesitis and extra-articular …

Objective Experimental and human data suggest that tumour necrosis factor (TNF) blockade
may affect B cell responses, in particular the induction of T cell-dependent (TD) humoral …

Introduction Biomarkers complementing clinical evaluations may help to reduce the length
and size of proof-of-concept (PoC) trials aimed to obtain quick" go/no go" decisions in the …

Objective Spondyloarthritis (SpA) can encompass axial, peripheral and extra-articular
disease manifestations. Patients are classified as axial or peripheral SpA depending on the …

Objectives To evaluate the efficacy and safety of adalimumab in patients with peripheral
spondyloarthritis (SpA) not fulfilling the criteria for ankylosing spondylitis (AS) or psoriatic …

Objective: Axial spondyloarthritis (axSpA) is a chronic inflammatory joint disease that usually
presents with axial symptoms, but can also present with peripheral and extra-articular …

Objectives A pivotal MRI study of knee arthritis indicated that enthesitis was more frequently
observed in established spondyloartritis (SpA) than rheumatoid arthritis (RA). Subsequent …

Objective. SpA is a phenotypically heterogeneous disease, with AS and PsA as its best
studied subtypes. This study aimed to investigate whether, despite a different phenotypic …

Objectives To assess the discriminatory capacity of various outcome measures and
response criteria in patients with peripheral spondyloarthritis (pSpA). Methods Data …